Jinzhuang Liao

7PUBLICATIONS
13CO-AUTHORS
Molecular targetsCancer diagnosisCancer cell biologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 20, 2026
Gracillin overcomes osimertinib resistance in NSCLC via dual inhibition of EGFR and Mcl-1.

Jinzhuang Liao, Qi Liang, Xuecheng Wu

|Oct 02, 2025
Demethoxycurcumin suppresses HK2-mediated glycolysis by targeting PTEN/Akt signaling.

Jinzhuang Liao, Shiming Tan, Shuangze Han

|Apr 08, 2025
E3 ligase Skp2-mediated stabilization of survivin contributes to radioresistance.

Shiming Tan, Ruirui Wang, Jinglin Fang

|Oct 29, 2024
Xanthohumol overcomes osimertinib resistance via governing ubiquitination-modulated Ets-1 turnover.

Ying Ma, Ruirui Wang, Jinzhuang Liao

|May 25, 2024
Xanthohumol Promotes Skp2 Ubiquitination Leading to the Inhibition of Glycolysis and Tumorigenesis in Ovarian Cancer.

Yi-Fu He, Yi-Ping Liu, Jin-Zhuang Liao

|Nov 06, 2023
Isoliquiritigenin Inhibits Oral Squamous Cell Carcinoma and Overcomes Chemoresistance by Destruction of Survivin.

Zhongsu Zhou, Shuangze Han, Jinzhuang Liao

Pageof 2